A first-of-its-kind device for pancreatic cancer treatment has been approved by the U.S. Food and Drug Administration.

Pancreatic cancer continues to be a devastating disease, with an overall 5-year survival rate of around 13%. Accounting for about 3% of all cancers, it is the third leading cause of cancer death in ...

Pancreatic cancer often hides in plain sight. Many of its earliest warnings look like everyday problems. A stubborn bout of indigestion, or a new backache that will not settle. A strange change in ...

New @hopkinskimmel research finds extra copies of chromosome 1q may drive the earliest stages of pancreatic cancer. › ...

Scientists have uncovered a hidden partnership between pancreatic cancer and the nervous system. Support cells in the ...

A feature of pancreatic cancer cells' surroundings determines whether they grow fast or become resistant to chemotherapy, a ...

A newly discovered link between pancreatic cancer and neural signaling reveals a promising drug target that slows tumor ...

Dr. Anju Goel, MD, MPH, is a public health consultant and physician with more than 10 years of experience in the California public health system. The pancreas is an organ that makes enzymes for ...

The overall risk of malignancy in pancreatic cysts may be as low as 0.5 to 1.5%, and the annual risk of progression is 0.5%. 7,15 Conversely, studies estimate that 15% of all pancreatic ...